lly. “We are really excited to be holding the series this spring.”
Participants who complete the Webinar Series will receive a Certificate of Completion and Continuing Education Credits are available.
The entire series of four Webinars are $199/person (Canadian). Those interested in participating can register at positivematters.com or contact Shannon Polly at spolly(at)accentuate-consulting(dot)com.
About Accentuate Consulting, LLC and Positive Matters
Accentuate Consulting is a D.C.-based consultancy which offers training in positive communications, giving effective feedback, strengths-based management, change management, and building optimism and resilience. President, Shannon Polly, recently co-authored an article in Talent Management Magazine “Does Happiness at Work Really Drive Results?” with Dan Bowling, former head of HR for Coca Cola. Visit http://www.accentuate-consulting.com for more information.
Louisa Jewell is the founder and president of the Canadian Positive Psychology Association and an organizational consultant who primarily works with leaders and teams to create positive and productive workplaces. Contact Louisa(at)positivematters(dot)com for more information.
Read the full story at http://www.prweb.com/releases/2013/3/prweb10579390.htm.
Page: 1 2 Related biology technology :1
Copyright©2012 Vocus, Inc.
All rights reserved
. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology2
. Positive Clinical Study Results for BSPs HyperQ Technology3
. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes4
. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office5
. Metabolex Announces Positive Results From its Clinical Study of Arhalofenate in Combination With Febuxostat6
. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium7
. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents8
. Idenix Reports Positive Interim Data for HCV Nucleotide Inhibitor, IDX1849
. Xention Reports Positive Phase 1 Data for New Atrial Fibrillation Drug10
. Echo Therapeutics to Present Positive Clinical Trial Results at the 72nd Scientific Sessions of the American Diabetes Association11
. Syndax Pharmaceuticals Announces Start of Phase 1/2 Study of Entinostat in Combination with Lapatinib in HER2-Positive Metastatic Breast Cancer